Check Credit Score
Check Credit Score
HomeNewsWorld

Wall Street Week Ahead: Bond investors look for Fed to justify steepening yield curve

The meeting will follow a surprise gain in the Labor Department's closely watched jobs report on Friday that pushed benchmark 10-year Treasury yields to the highest since early March.

June 06, 2020 / 08:07 PM IST

Expectations that the global economy has dodged the worst-case coronavirus pandemic scenarios have led to a dramatic sell-off in US government bonds from their record highs, pushing the yield curve to its steepest level since March.

Investors will get a chance next week to see whether the US Federal Reserve agrees with their optimism.

The US central bank's two-day meeting, ending on Wednesday, will be the first since April when Fed Chair Jerome Powell said the US economy could feel the weight of the economic shutdown for more than a year.

The meeting will follow a surprise gain in the Labor Department's closely watched jobs report on Friday that pushed benchmark 10-year Treasury yields to the highest since early March.

"The sell-off in the bond market in the last few weeks seems to be justified," said Subadra Rajappa, head of US rates strategy at Societe Generale.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

While the Fed could introduce additional bond-buying programs known as quantitative easing or yield-curve control measures to target short-term rates, fund managers say they expect yields will need to rise significantly to justify any intervention in the bulk of the curve. Instead, they are watching for hints that the central bank believes the worst part of the coronavirus crisis has passed.

"They are really in this transition phase," said Eric Stein, co-director of global income and portfolio manager at Eaton Vance. "Markets are functioning, if not all the way back to pre-shock levels, with very strong debt issuance and market improvement, even though the real economy is incredibly weak."

As a result, Stein is looking for signs that the Fed believes the economic rebound can support the rise in yields.

"The Fed will be OK with a slow creep higher, particularly with a backdrop of a recovery, but if it moves too much and destabilizes the recovery, there's a reason for concern," he said.

Ed Al-Hussainy, senior interest rate analyst at Columbia Threadneedle, expects the Fed to focus on its newly announced Main Street Lending Program to support small- and medium-sized businesses facing financial strain from the pandemic, rather than introducing significant new stimulus measures.

"The Fed is likely to communicate that there is more scope for fiscal measures but that is a very uncomfortable spot to be in," he said. "We won't have a clear sense of direction of the economy until well into the fourth quarter because all the sequential data now is massively positive."

The manufacturing ISM index rose to 43.1 in May from 41.5 in April, while weekly jobless claims fell to 1.877 million from 2.126 million the week before.

"Recent economic reports in the US have been uniformly weak, though not any worse than expected," said Kevin Cummins, senior US economist at NatWest Markets.

Eddy Vataru, lead portfolio manager at Osterweis Capital Management, said the larger risk for the Fed is that rates remain too low, making it unlikely that there will be a significant push for yield curve-control measures.

"We can now discredit the worst outcomes of the virus. The sentiment around the risks around the virus have really changed," he said, pointing to declining infection and fatality rates in coronavirus hot spots such as the New York City region.

As a result, he is moving into corporate debt and mortgage-backed securities and shying away from Treasuries, which he said have "no investment value" at their current yields.

"At the end of the day, we have a ton of stimulus, both fiscal and monetary, and the markets have reacted to it," he said.

Reuters

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347